Related Experiment Video
Updated: Aug 10, 2026

Imaging the Human Immunological Synapse
Published on: December 26, 2019
A functional role for interleukin (IL)-4-driven cyclic amp accumulation in human b lymphocytes
C E McKay1, E L Hewitt, B W Ozanne
1Division of Biochemistry & Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, G12 8QQ.
Insights
Interleukin-4 (IL-4) regulates CD25 gene expression in B cells. The cAMP/protein kinase A (PKA) pathway is key, attenuating a negative regulator to control CD25 promoter activity.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Interleukin-4 (IL-4) is a cytokine crucial for B lymphocyte function.
- CD25, the alpha-subunit of the IL-2 receptor, is expressed on activated B cells.
- Regulation of CD25 expression is vital for B cell proliferation and differentiation.
Purpose of the Study:
- To investigate the role of the cAMP/protein kinase A (PKA) pathway in IL-4-mediated CD25 gene regulation.
- To identify the molecular mechanism by which IL-4 controls CD25 expression in human B lymphocytes.
- To elucidate the function of a negative regulatory element (NRE) in the CD25 promoter.
Main Methods:
- Analysis of CD25 gene expression in human tonsillar B cells and a B-cell line.
- Investigation of signaling pathways involving cAMP, PKA, and protein kinase C (PKC).
- Use of reporter gene assays to assess promoter activity.
Main Results:
- The cAMP/PKA pathway in IL-4 signaling attenuates the activity of a protein binding to a negative regulatory element (NRE) in the CD25 promoter.
- Agents that increase cAMP levels mimic IL-4's effect, while PKA inhibitors block it.
- In a B-cell line lacking cAMP response, forskolin restored IL-4-induced CD25 expression.
Conclusions:
- The cAMP/PKA pathway plays a critical role in IL-4-induced CD25 gene expression in human B cells.
- IL-4 signaling modulates CD25 expression by inhibiting a repressor protein at the NRE site.
- Targeting the cAMP/PKA pathway could influence B cell responses and immune regulation.
Abstract:
Interleukin-4 (IL-4) regulates the expression of the 55-kDa alpha-subunit (CD25) of the IL-2 receptor complex in human B lymphocytes. This report suggests that the cAMP/protein kinase A (PKA) component of the IL-4 receptor signalling programme in human tonsillar B cells has a functionally important role in regulating expression of the CD25 gene by attenuating activity of a protein binding to a potent negative regulatory element (NRE) in the CD25 promoter; this effect can be mimicked by agents that elevate cAMP and blocked by inhibitors of PKA but not protein kinase C (PKC). In a B-cell line that fails to elevate cAMP, attenuate NRE-binding protein (NRE-BP) activity or express CD25 following IL-4 treatment, stimulation of cAMP accumulation by forskolin facilitates IL-4-mediated induction of both the endogenous gene and an exogenous reporter gene under the control of a minimal promoter/enhancer fragment of the CD25 gene.
Related Concept Videos
Intracellular Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

